Generic Name |
Rivoceranib + Paclitaxel | |
---|---|---|
IND |
Apatinib | |
Brand Name (US) |
||
Manufacturer |
||
Drug Type |
||
Delivery |
Oral and Intravenous | |
Approval Status |
||
Indications |
||
Overall Strategy |
||
Strategy |
||
Drug Category |
VEGFR inhibitor + Microtubule stabilizer |
Links |
|
Trials of this drug |
|
|
Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor |
Trial results |